Stuart, B., Factors impacting on the problem of antibiotic resistance (2002) Antimicrob. Agents Chemother., 1, pp. 25-30; World Health Report. 2003. Shaping the future. Geneva, World Health Organization; Abuzaid, A., Hamouda, A., Amyes, S.G., Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacDE and qacE efflux pump genes and antibiotic resistance (2012) J. Hosp. Infect., 81, pp. 87-91; Goffin, C., Ghuysen, J.M., Multimodular penicillin-binding proteins: An enigmatic family of orthologs and paralogs (1998) Microbiol. Mol. Biol. Rev., 62, pp. 1079-1093; Walsh, V., Time: The back-door of perception (2003) Trends Cogn. Sci., 7, pp. 335-338; Sauvage, E., Kerff, F., Terrak, M., Ayala, J.A., Charlier, P., The penicillin-binding proteins: Structure and role in peptidoglycan biosynthesis (2008) FEMS Microbiol. Rev., 32, pp. 234-258; Massova, I., Mobashery, S., Kinship and diversification of bacterial penicillin-binding proteins and Beta-lactamases (1998) Antimicrob. Agents Chemother., 42, pp. 1-17; Spratt, B.G., Cromie, K.D., Penicillin-binding proteins of Gramnegative bacteria (1988) Rev. Infect. Dis., 10, pp. 699-711; McCormick, M.H., Stark, W.M., Pittenger, G.E., Pittenger, R.C., McGuire, J.M., Vancomycin, a new antibiotic (1956) I: Chemical and Biologic Properties. Antibiot. Annu., 3, pp. 606-611; Carter, J.T., Rice, E.W., Buchberger, S.G., Lee, Y., Relationships between levels of heterotrophic bacteria and water quality parameters in a drinking water distribution system (2000) Water Res., 34, pp. 1495-1502; Schlunzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A., Franceschi, F., Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria (2001) Nature, 413, pp. 814-821; Chopra, I., Roberts, M., Tetracycline antibiotics: Mode of action, applications, molecular biology and epidemiology of bacterial resistance (2001) Microbiol. Mol. Biol. Rev., 65, pp. 232-260; Mascaretti, O.A., (2003) Bacteria Versus Antibacterial Agents: An Integrated Approach, , ASM Press: Washington, DC; Zinner, S.H., Mayer, K.H., Sulfonamides and trimethoprim (2005) Principles and Practice of Infectious Diseases, pp. 440-451. , Mandell, G.L.; Bennett, J.E.; Dolin, R.; eds; Elsevier, Churchill, Livingstone; Okoh, A.I., Igbinosa, E.O., Antibiotic susceptibility profiles of some Vibrio strains isolated from waste water final effluents in a rural community of the Eastern Cape Province of South Africa (2010) BMC Microbiol., 10, pp. 143-148; Spratt, B.G., Bowler, L.D., Zhang, Q.Y., Riou, J.Y., Interspecies recombination between the penA genes of Neisseria meningitidis and commensal species during the emergence of penicillin resistance in N (1994) Meningitidis: Natural Events and Laboratory Simulation. J. Bacteriol., 176, pp. 333-337; Fisher, J.F., Mobashery, S., (2010) 8.13-Enzymology of Bacterial Resistance, pp. 443-487. , In: Comprehensive Natural Products II; Elsevier: Oxford; (2007) A Safer Future. in Global Public Health Security in 21st Century, , World Health Report. World Health Organization, Geneva; Berdy, J., Thoughts and facts about antibiotics: Where we are now and where we are heading (2012) J. Antibiot. (Tokyo), 65, pp. 385-395; World Health Report. 2011. Global Tuberculosis Control. World Health Organization, Geneva; Kohler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A.L., Pechere, J.C., Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa (1997) Antimicrob. Agents Chemother., 41, pp. 2540-2543; Davies, J.E., Origins, acquisition and dissemination of antibiotic resistance determinants (1997) Ciba Found. Symp., 207, pp. 15-27; Deplano, A., Zekhnini, A., Allali, N., Couturier, M., Struelens, M.J., Association of mutations in grlA and gyrA topoisomerase genes with resistance to ciprofloxacin in epidemic and sporadic isolates of methicillin-resistant Staphylococcu aureus (1997) Antimicrob. Agents Chemother., 41, pp. 2023-2025; Bush, K., Fisher, J.F., Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gramnegative bacteria (2011) Ann. Rev. Microbiol., 65, pp. 455-478; Weese, S.J., Antimicrobial resistance in companion animals (2008) Anim. Health Res. Rev., 9, pp. 169-176; Li, X.Z., Nikaido, H., Efflux-mediated drug resistance in bacteria (2004) Drugs, 64, pp. 159-204; Nikaido, H., Takatsuka, Y., Mechanisms of RND multidrug efflux pumps (2009) Biochim. Biophys. Acta, 1794, pp. 769-781; Davidson, A.L., Chen, J., ATP-binding cassette transporters in bacteria (2004) Annu. Rev. Biochem., 73, pp. 241-268; Saier, M.H., Jr., Beatty, J.T., Goffeau, A., Harley, K.T., Heijne, W.H., Huang, S.C., Jack, D.L., Virk, P.S., The major facilitator superfamily (1999) J. Mol. Microbiol. Biotech., 1, pp. 257-279; Saier, M.H., Jr., Families of transmembrane sugar transport proteins (2000) Mol. Microbiol., 35, pp. 699-710; Reddy, V.S., Shlykov, M.A., Castillo, R., Sun, E.I., Saier, M.H., Jr., The major facilitator super family (MFS) revisited (2012) FEBS J., 279, pp. 2022-2035; Kasho, V.N., Smirnova, I.N., Kaback, H.R., Sequence alignment and homology threading reveals prokaryotic and eukaryotic proteins similar to lactose permease (2006) J. Mol. Biol., 358, pp. 1060-1070; Sugihara, J., Smirnova, I., Kasho, V., Kaback, H.R., Sugar recognition by CscB and LacY (2011) Biochemistry, 50, pp. 11009-11014; Madej, M.G., Dang, S., Yan, N., Kaback, H.R., Evolutionary mixand-match with MFS transporters (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 5870-5874; Omote, H., Hiasa, M., Matsumoto, T., Otsuka, M., Moriyama, Y., The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations (2006) Trends Pharmacol. Sci., 11, pp. 587-593; Bay, D.C., Rommens, K.L., Turner, R.J., Small multidrug resistance proteins: A multidrug transporter family that continues to grow (2008) Biochim. Biophys. Acta., 1778, pp. 1814-1838; Matsumoto, T., Kanamoto, T., Otsuka, M., Omote, H., Moriyama, Y., Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter (2008) Am. J. Physiol. Cell Physiol., 294, pp. C1074-C1078; Poole, K., Bacterial multidrug efflux pumps serve other functions (2008) Microbe, 3, pp. 179-185; Elkins, C.A., Mullis, L.B., Mammalian steroid hormones are substrates for the major RND and MFStype tripartite multidrug efflux pumps of Escherichia coli (2006) J. Bacteriol., 188, pp. 1191-1195; Fang, F.C., Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies (2004) Nat. Rev. Microbiol., 2, pp. 820-832; Camilli, A., Bassler, B.L., Bacterial small-molecule signaling pathways (2006) Science, 311, pp. 1113-1116; Lesprit, P., Faurisson, F., Join-Lambert, O., Roudot-Thoraval, F., Foglino, M., Vissuzaine, C., Carbon, C., Role of the quorum sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats (2003) Am. J. Respir. Crit. Care Med., 167, pp. 1478-1482; Lynch, S.V., Dixon, L., Benoit, M.R., Brodie, E.L., Keyhan, M., Hu, P., Ackerley, D.F., Matin, A., Role of the rapA gene in controlling antibiotic resistance of Escherichia coli biofilms (2007) Antimicrob. Agents Chemother., 51, pp. 3650-3658; Dale, G.E., Broger, C., Arcy, A.D., Hartman, P.G., DeHoogt, R., Jolidon, S., Kompis, I., Oefner, C., A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance (1997) J. Mol. Biol., 266, pp. 23-30; Pikis, A., Donkersloot, J.A., Rodriquez, W.J., Keith, J.M., A conservative amino acid mutation in the chromosome encoded dihydrofolate reductase confers trimethoprim resistance in Streptococcus pneumoniae (1998) J. Infect. Dis., 178, pp. 700-706; Turnidge, J., Collignon, P., Resistance to fusidic acid (1999) Int. J. Antimicrob. Agents, 12, pp. S35-S44; Besier, S., Ludwig, A., Brade, V., Wichelhaus, T.A., Molecular analysis of fusidic acid resistance in Staphylococcus aureus (2003) Mol. Microbiol., 47, pp. 463-469; Yu, H.S., Lee, J.C., Kang, H.Y., Ro, D.W., Chung, J.Y., Jeong, Y.S., Tae, S.H., Cho, D.T., Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades (2003) J. Clin. Microbiol., 41, pp. 5429-5433; Wolter, D.J., Hanson, N.D., Lister, P.D., Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance (2004) FEMS Microbiol. Lett., 236, pp. 137-143; Ruiz, J., Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection (2003) J. Antimicrob. Chemother., 51, pp. 1109-1117; Sonntag, I., Schwarz, H., Hirota, Y., Henning, U., Cell envelope and shape of Escherichia coli: Multiple mutants missing the outer membrane lipoprotein and other major outer membrane proteins (1978) J. Bacteriol., 136, pp. 280-285; Vaara, M., Agents that increase the permeability of the outer membrane (1992) Microbiol. Rev., 56, pp. 395-411; Ambler, R.P., The structure of beta-lactamases (1980) Philos. Trans. R. Soc. Lond. B Biol. Sci., 289, pp. 321-331; Bush, K., Jacoby, G.A., Medeiros, A.A., A functional classification scheme for beta-lactamases and its correlation with molecular structure (1995) Antimicrob. Agents Chemother., 39, pp. 1211-1233; Tzouvelekis, L.S., Bonomo, R.A., SHV-type b-lactamases (1999) Curr. Pharm. Des., 5, pp. 847-864; Livermore, D.M., Li, X.Z., Ma, D., Nikaido, H., Role of efflux pump(s) in intrinsic resistances of Pseudomonas aeruginosa: Active efflux as a contributing factor to beta-lactam resistance (1995) J. Antimicrob. Agents Chemother., 38, pp. 1732-1741; Barthelemy, M., Peduzzi, J., Labia, R., Distinction entre les structures primaires des beta-lactamases TEM-1 et TEM-2 (1985) Ann. Inst. Past. Microbiol., 136 (3), pp. 311-321; Bush, K., Jacoby, G.A., An updated functional classification of-lactamases (2010) Antimicrob. Agents Chemother., 54, pp. 969-976; Naseer, U., Haldorsen, B., Tofteland, S., Hegstad, K., Scheutz, F., Simonsen, G.S., Sundsfjord, A., Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway (2009) APMIS, 117, pp. 526-536; Eonnberg, A., Meolling, P., Zimmermann, J., Soderquist, B., Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases with focus on CTX-M in a low-endemic area in Sweden (2011) APMIS, 119, pp. 287-295; Nielsen, J.B., Albayati, A., Jorgensen, R.L., Hansen, K.H., Lundgren, B., Schonning, K., An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum betalactamase-producing lineage in the Copenhagen area (2012) Eur. J. Clin. Microbiol. Infect., 32, pp. 431-436; Azam, M., Jan, A.T., Haq, Q.M.R., BlaCTX-M-152, a novel variant of CTX-M-group-25, identified in Kluyvera georgiana isolate from river Yamuna, India (2016) Front. Microbiol., 7, p. 176; Weldhagen, G.F., Poirel, L., Nordmann, P., Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: Novel developments and clinical impact (2003) Antimicrob. Agents Chemother., 47, pp. 2385-2392; Poirel, L., Girlich, D., Naas, T., Nordmann, P., OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid-and integron-located gene (2001) Antimicrob. Agents Chemother., 45, pp. 447-453; Bradford, P.A., Extended spectrum beta-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat (2001) Clin. Microbiol. Rev., 14, pp. 933-951; Naas, T., Poirel, L., Nordmann, P., Minor extended-spectrum betalactamases (2008) Clin. Microbiol Infect., 14, pp. 42-52; Neuhauser, M.M., Weinstein, R.A., Rydman, R., Danziger, L.H., Karam, G., Quinn, J.P., Antibiotic resistance among gram negative bacilli in US intensive care units: Implications for fluoroquinolone use (2003) JAMA, 289, pp. 885-888; Petroni, A., Corso, A., Melano, R., Cacace, L.M., Bru, M.A., Rossi, A., Galas, M., Plasmidic extended spectrum-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina (2002) Antimicrob. Agents Chemother., 46, pp. 1462-1468; Poirel, L., Le Thomas, I., Naas, T., Karim, A., Nordmann, P., Biochemical sequence analyses of GES-1, a novel class A extendedspectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae (2000) Antimicrob. Agents Chemother., 44, pp. 622-632; Poirel, L., Weldhagen, G.F., Naas, T., De Champs, C., Dove, M.G., Nordmann, P., GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem (2001) Antimicrob. Agents Chemother., 45, pp. 2598-2603; Poirel, L., Naas, T., Guibert, M., Chaibi, E.B., Labia, R., Nordmann, P., Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene (1999) Antimicrob. Agents Chemother., 43, pp. 573-581; Poirel, L., Van De Loo, M., Mammeri, H., Nordmann, P., Association of plasmid-mediated quinolone resistance with extendedspectrum beta-lactamase VEB-1 (2005) Antimicrob. Agents Chemother., 49, pp. 3091-3094; Naas, T., Mikami, Y., Imai, T., Poirel, L., Nordmann, P., Characterization of In53, a class 1 plasmid and composite transposonlocated integron of Escherichia coli which carries an unusual array of gene cassettes (2001) J. Bacteriol., 183, pp. 235-249; Morin, A.S., Poirel, L., Mory, F., Labia, R., Nordmann, P., Biochemical-genetic analysis and distribution of DES-1, an Ambler class A extended-spectrum beta-lactamase from Desulfovibrio desulfuricans (2002) Antimicrob. Agents Chemother., 46, pp. 3215-3222; Bonnet, R., Sampaio, J.L., Chanal, C., Sirot, D., De Champs, C., Viallard, J.L., Labia, R., Sirot, J., A novel class A extendedspectrum b-lactamase (BES-1) in Serratia marcescens isolated in Brazil (2000) Antimicrob. Agents Chemother., 44, pp. 3061-3068; Silva, J., Aguilar, C., Ayala, G., Estrada, A.M., Garza-Ramos, U., Lara-Lemus, R., Ledezma, L., TLA-1: A new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli (2000) Antimicrob. Agents Chemother., 44, pp. 997-1003; Alcantar-Curiel, D., Tinoco, J.C., Gayosso, C., Carlos, A., Daza, C., Perez-Prado, M.C., Salcid, L., Aranda-Alpuche, M.C., Nosocomial bacteremia and urinary tract infections caused by extended-spectrum ß-lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes (2004) Clin. Infect. Dis., 38, pp. 1067-1074; Brown, A.G., Clavulanic acid, a novel beta-lactamase inhibitora case study in drug discovery and development (1986) Drug Des. Deliv., 1, pp. 1-21; Brown, S., Banter, C., Young, H.K., Amyes, S.G.B., Limitation of Acinobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2 (1998) Lancet, 351, pp. 186-187; Bush, K., Macalintal, C., Rasmussen, B.A., Lee, V.J., Yang, Y., Kinetic interactions of tazobactam with beta-lactamases from all major structural classes (1993) Antimicrob. Agents Chemother., 37, pp. 851-858; Chen, Y., Delmas, J., Sirrot, J., Bonnet, R., Shoichet, B., The acylation mechanism of CTX-M B-lactamase at 0.88 ?A resolution (2007) J. Am. Chem. Soc., 129, pp. 5378-5380; Delmas, J., Leyssene, D., Dubois, D., Birck, C., Vazeille, E., Robin, F., Bonnet, R., Structural insights into substrate recognition and product expulsion in CTX-M enzymes (2010) J. Mol. Biol., 400, pp. 108-120; English, A.R., Retsema, J.A., Girard, A.E., Lynch, J.E., Barth, W.E., CP-45,899, a-lactamase inhibitor that extends the antibacterial spectrum of-lactams: Initial bacteriological characterization (1978) Antimicrob. Agents Chemother., 14, pp. 414-419; Fisher, J., Belasco, J.G., Charnas, R.L., Khosla, S., Knowles, J.R., Lactamase inactivation by mechanism-based reagents (1980) Philos. Trans. R. Soc. Lond. B Biol. Sci., 289, pp. 309-319; Gin, A., Dilay, L., Karlowsky, J.A., Walkty, A., Rubinstein, E., Zhanel, G.G., Piperacillin-tazobactam: A beta-lactam/betalactamase inhibitor combination (2007) Expert Rev. Anti-Infect. Ther., 5, pp. 365-383; Sulakvelidze, A., Kutter, E., Bacteriophage therapy in humans (2005) Bacteriophages: Biology and Applications, pp. 381-436. , Kutter, E.; Sulakvelidze, A.; Eds. CRC Press: USA; Summers, W.C., Bacteriophage therapy (2001) Ann. Rev. Microbiol., 55, pp. 437-451; Hausler, T., (2006) Viruses Vs Superbugs-A Solution to the Antibiotic Crisis, , Palgrave Macmillan: UK; Russel, M., Model, P., Filamentous phage (2006) The Bacteriophages, pp. 146-160. , Calendar, R.L.; Abedon, S.T.; Eds. Oxford University Press: UK; Fujisawa, H., Watanabe, K., Suma, K., Origuchi, K., Matsufuji, H., Seki, T., Ariga, T., Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds (2009) Biosci. Biotechnol. Biochem., 73, pp. 1948-1955; Cutler, R.R., Wilson, P., Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus (2004) Br. J. Biomed. Sci., 61, pp. 71-74; Agarwal, K., Varma, R., Some ethnomedicinal plants of Bhopal district used for treating stone diseases (2012) Int. J. Pharm. Life Sci., 1, pp. 1356-1362; Martin, G.E., Seamonn, K.B., Brown, F.M., Shanahan, M.F., Roberts, P.E., Henderson, P.J., Forskolin specifically inhibits the bacterial galactose-H+ transport protein, GalP (1994) J. Biol. Chem., 269, pp. 24870-24877; Pyleris, E., Giamarellos-Bourboulis, E.J., Tzivras, D., Koussoulas, V., Barbatzas, C., Pimentel, M., The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: Relationship with irritable bowel syndrome (2012) Dig. Dis. Sci., 57, pp. 1321-1329; Dhanya Kumar, N.M., Sidhu, P., The antimicrobial activity of Azadirachta indica, Glycyrrhiza glabra, Cinnamum zeylanicum, Syzygium aromaticum, Accacia nilotica on Streptococcus mutans and Enterobacter feacalis-An in vitro study (2011) Endodontology, 23, pp. 16-23; Yerima, M.B., Jodi, S.M., Oyinbo, K., Maishanu, H.M., Farouq, A.A., Junaidu, A.U., Al-Mustapha, M.N., Shinkafi, A.L., Effect of neem extracts (Azadirachta indica) on bacteria isolated from adult mouth (2012) Nig. J. Basic Appl. Sci., 20, pp. 64-67; Nat, V.D., Klerx, J.P., Dijk, H.V., DeSilva, K.T., Labadie, R.P., Immunomodulatory activities of an aqueous extract of Azadirachta indica stem bark (1987) J. Ethnopharm., 19, pp. 125-131; Houchi, S., Mahdadi, R., Messasma, Z., Sahli, F., The inhibitory effect of methanolic and aqueous extracts of terminalia chebula dried fruits on metallobetalactamases of acinetobacter baumannii (2014) Int. J. Pharm. Pharm. Sci., 6, pp. 579-582; Sato, Y., Oketani, H., Singyouchi, K., Ohtsubo, T., Kihara, M., Shibata, H., Higuti, T., Extraction and purification of effective antimicrobial constituents of Terminalia chebula Retz (1997) Against Methicillinresistant Staphylococcus Aureus. Bull. Pharm. Bull., 20, pp. 401-404; Bag, A., Bhattacharyya, S.K., Pal, N.K., Chattopadhyay, R.R., Synergistic effect of Terminalia chebula against multidrug-resistant uropathogenic Escherichia coli (2011) Med. Arom. Plant Sci. Biotech., 5, pp. 70-73; Al-Jiffri, O., El-Sayed, Z.M.F., Al-Sharif, F.M., Urinary tract infection with Escherichia coli and antibacterial activity of some plant extracts (2011) Int. J. Microbiol. Res., 2, pp. 1-7; Rahman, M.M., Rahman, M.A., Islamand, M.S., Alam, M.F., In vitro controlling of selected human diarrhea causing bacteria by clove extracts (Syzygium aromaticum L.) (2011) Int. J. Biomol. Biomed., 1, pp. 17-26; Saeed, M., Nadeem, M., Khan, M.R., Shabbir, M.A., Shehzad, A., Amir, R.M., Antimicrobial activity of Syzygium aromaticum extracts against food spoilage bacteria (2013) Afr. J. Microbiol. Res., 7, pp. 4848-4856; Anjana, S., Rani, V., Padmini, R., Antibacterial activity of some medicinal plants used by tribals against UTI causing pathogens (2009) World Appl. Sci. J., 7, pp. 332-339; Srinivasan, D., Nathan, S., Suresh, T., Lakshmana Perumalsamy, P., Antimicrobial activity of certain Indian medicinal plants used in folkloric medicine (2001) J. Ethnopharmacol., 74, pp. 217-220